Human T-lymphotropic virus type III or lymphoadenopathy associated virus (HTLV-Il/LAV) is the cause of acquired immune deficiency syndrome (AIDS) Human T-lymphotropic virus type III (HTLV-III) or the lymphoadenopathy associated virus (LAV) is etiologically linked to acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) (1-4). The overall genetic structure of HTLV-III/LAV is similar to that of other animal retroviruses. However, besides gag, pol, and env genes, DNA sequence analysis of HTLV-III/LAV genome predicted two additional open reading frames or potential genes (5-8), termed by us and others sor (short open reading frame) and 3' orf (3' open reading frame). The presence of a third gene, termed tat (transactivation of transcription), was also suggested (9-12). Thus, HTLV-III/LAV contains coding potential for three genes that are specific to this virus. Two of these putative genes, sor and 3' orf, are unique to HTLV-III but a functional analog of the third gene, tat, is also carried by other members of the HTLV-bovine leukemia virus (BLV) group of retroviruses (9-13). We and others have localized the tat gene of HTLV-III to a region between the putative sor and the env genes (10, 12), a region of the genome previously thought to be noncoding. This is distinct from the other members of the HTLV-BLV group where tat gene is located downstream from the env gene. Thus, even the tat gene is organized differently in HTLV-III. We report here that sor, tat, and 3' orf genes all contain intron(s) and are respectively translated into polypeptides with apparent mobility of 24-25 kDa, 14-15 kDa, and 26-28 kDa on NaDodSO4/PAGE. These gene products display differential immune reactivity for HTLV-III positive human sera, the 3' orfgene product being the most immune reactive. The results demonstrate the existence of three new HTLV-III antigens.
analysis revealed another gene with transactivating function, termed tat. We have now structurally identified and functionally characterized these HTLV-Ill specific genes by way of cDNA cloning. DNA sequence analysis of the clones shows that the tat and 3' orf genes contain three exons and their transcription into functional mRNA involves two splicing events and that the sor gene contains at least two exons. In vitro transcription and translation of the cloned spliced sequences show that the sor, tat, and 3' orf genes code for polypeptides with apparent mobility of 24-25 kDa, 14-15 kDa, and 26-28 kDa, respectively. All three polypeptides are immune reactive and are immunogenic in the natural host. The results demonstrate that the three extra open reading frames of HTLV-Il, two of which are unique to HTLV-III, are in fact genes that function in vivo and further allow the identification of three new and previously unrecognized HTLV-Ill antigens with differential immunogenicity in individuals with acquired immune deficiency syndrome and related disorders.
Human T-lymphotropic virus type III (HTLV-III) or the lymphoadenopathy associated virus (LAV) is etiologically linked to acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) (1) (2) (3) (4) . The overall genetic structure of HTLV-III/LAV is similar to that of other animal retroviruses. However, besides gag, pol, and env genes, DNA sequence analysis of HTLV-III/LAV genome predicted two additional open reading frames or potential genes (5) (6) (7) (8) , termed by us and others sor (short open reading frame) and 3' orf (3' open reading frame). The presence of a third gene, termed tat (transactivation of transcription), was also suggested (9) (10) (11) (12) . Thus, HTLV-III/LAV contains coding potential for three genes that are specific to this virus. Two of these putative genes, sor and 3' orf, are unique to HTLV-III but a functional analog of the third gene, tat, is also carried by other members of the HTLV-bovine leukemia virus (BLV) group of retroviruses (9-13). We and others have localized the tat gene of HTLV-III to a region between the putative sor and the env genes (10, 12) , a region of the genome previously thought to be noncoding. This is distinct from the other members of the HTLV-BLV group where tat gene is located downstream from the env gene. Thus, even the tat gene is organized differently in HTLV-III. We report here that sor, tat, and 3' orf genes all contain intron(s) and are respectively translated into polypeptides with apparent mobility of 24-25 kDa, 14-15 kDa, and 26-28 kDa on NaDodSO4/PAGE. These gene products display differential immune reactivity for HTLV-III positive human sera, the 3' orfgene product being the most immune reactive. The results demonstrate the existence of three new HTLV-III antigens.
MATERIALS AND METHODS cDNA Cloning and DNA Sequencing. Poly(A)-selected RNA from HTLV-III-infected H4 cells, isolated as described (14, 15) , was used to construct cDNA libraries as reported (10) . The libraries were screened with subgenomic HTLV-III probes to obtain clones containing specific HTLV-III sequences (10, 11). The selected clones were characterized by restriction mapping and DNA sequencing by the method of Maxam and Gilbert (16) .
In Vitro Transcription and Translation. The inserts of selected cDNA clones were transferred to the vector pSP6 that transcribes inserted DNA under the influence of SP6 promoter (17) . RNA was transcribed in vitro after linearization of the plasmid DNA with specific restriction enzymes. It was translated in vitro by using rabbit reticulocyte translation system and [35S]methionine, and the products were analyzed by 12% NaDodSO4/PAGE and radioautography by the standard procedures.
Immunoprecipitation with Human Sera. The in vitro translation products were incubated with normal human serum for 1-2 hr at 4°C. Suspension of Staphylococcus aureus (Staph A) cells was then added, and incubation was continued for an additional 1 hr. The sample was centrifuged, and the supernatant was divided into two equal parts, one of which was incubated with immune serum at 4°C for 18-24 hr. A suspension of Staph A was added to each sample and incubated at 4°C for 1 hr. The samples were centrifuged, and the pellets were repeatedly and sequentially washed with 50 mM Tris HCl (pH 7.4)/50 mM EDTA/0.05% Nonidet P-40/1% aproteinin containing 0.5 M NaCl or 0.15 mM NaCl. The pellets were suspended in 75 mM Tris HCl (pH 6.8)/0.7 mM 2-mercaptoethanol/2% (wt/vol) NaDodSO4/10% (vol/ vol) glycerol/0.001% bromophenol blue, boiled for 10 min, and centrifuged. The supernatants were subjected to 12% NaDodSO4/PAGE analysis.
RESULTS
cDNA Clones of HTLV-III Specific Genes. To identify HTLV-III specific genes, we took the direct approach of Abbreviations: HTLV-III/LAV, human T-lymphotropic virus type III/lymphoadenopathy associated virus; AIDS, acquired immune deficiency syndrome; bp, base pair(s); kb, kilobase(s).
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predominant polypeptide of25-26 kDa forXba I as well as Sma I linearized plasmid pSP-1 DNA. The 25-26 kDa polypeptide was also specifically immune precipitated from the translation products of Xba I as well as Sma I linearized plasmid pSP-12 DNA. Similar results were obtained with plasmid pSP-3 DNA, except the apparent size ofthis polypeptide was 27-28 kDa (Fig.  4) . The marginal detection of this polypeptide in translation products of BamHI-digested pSP-1 and pSP-3 plasmid DNAs was probably the result ofincomplete enzyme digestions; it was not detected for BamHI-digested pSP-12 plasmid DNA. Instead, translation products of BamHI-digested pSP-12 plasmid DNA displayed a band at 23-24 kDa that was immune precipitated with HTLV-III-positive serum but also to a lesser extent with some normal human sera (see Table 1 ). Consistent with our interpretation of the translation products noted above, we infer that the 26-28 kDa and 23-24 kDa polypeptides are the immune reactive products of 3' orf and sor open reading frames, respectively. Immunoprecipitation of the 14-15 kDa tat gene product was not obvious with this particular HTLV-III-positive serum but could be detected to varying extent by some of the other HTLV-III-positive sera as shown in Fig. 5 and listed in Table 1 .
DISCUSSION
The HTLV-Ill open reading frames termed sor, tat, and 3' orf are specific to this virus and two of these, sor and 3' orf, are Our results allow the structural definition of the three HTLV-III specific genes. We have previously characterized the functional domain of the tat gene (10) . Like the tat gene, the 3' orfgene (clone 3) also consists of three exons (287 bp, 69 bp, and 1258 bp) and two introns (5268 bp and 2330 bp), and its transcription into a functional mRNA involves double splicing. The 3' orfgene differs from the tat gene in having a truncated second exon involving splicing out of the putative initiation codon of the tat gene product (10 The products of the sor, tat, and 3' orf genes are immunogenic in vivo, thus identifying three new antigens for HTLV-III, in addition to the previously described gag and env gene products (19) (20) (21) (22) . The three gene products appear to be differentially immunoreactive and immunogenic, the 3' orfgene product apparently being the most potent and the sor gene product being the least potent in this regard. The lesser immunogenicity of the sor gene product may be due to its diminished expression in vivo and its particular intracellular localization, or it may be related to its structure (Fig. 6) . The predicted amino acid sequence of the sor gene product does not contain a cluster of amino acid residues that will impart to this protein hydrophilic structure with ,-turns-two param- Hydrophobicity profile and predicted secondary structure of sor (a) and 3' orf(b) polypeptides analyzed according to Kyte and Doolittle (23) and Chou and Fasman (24) . Secondary structure is depicted by boxes and vertical lines represent amino acid residues. Open box, a-helix; hatched box, 3-sheets; closed box, /3-turns.
eters generally thought to be responsible for strong immunogenicity (23, 24) . Notably, the predicted amino acid sequence of both the sor and tat gene products lacks typical sequence (-aspargine-Xaa-threonine or serine-) that generally serves as a glycosylation site and such a sequence is present twice in the predicted sequence of 3' orf gene product.
With regard to any correlation between the progression of the disease and expression of the HTLV-III specific genes, the survey reported here is too small to detect meaningful trends. We think it is premature to draw conclusions from the observation that antibodies to the 3' orf gene product were detected in all but one ofthe six sera from patients with AIDS and ARC but in only one out of four sera from HTLV-IIIpositive healthy homosexual individuals in this study. Further, some of the normal human sera reacted, though poorly, with the sor gene product. Although we cannot presently rule out artifactual interactions, this may suggest that a normal cellular gene with some homology to the sor gene exists, and its product is synthesized in some instances. The differential expression of the sor, tat, and 3' orfgenes in vivo may reflect mutual modulatory role(s) of the products of these genes.
